133 related articles for article (PubMed ID: 10819171)
1. Discovery of a muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors among 2-[(1S,3S)-3-sulfonylaminocyclopentyl]phenylacetamide derivatives.
Mitsuya M; Ogino Y; Kawakami K; Uchiyama M; Kimura T; Numazawa T; Hasegawa T; Ohtake N; Noguchi K; Mase T
Bioorg Med Chem; 2000 Apr; 8(4):825-32. PubMed ID: 10819171
[TBL] [Abstract][Full Text] [Related]
2. J-104129, a novel muscarinic M3 receptor antagonist with high selectivity for M3 over M2 receptors.
Mitsuya M; Mase T; Tsuchiya Y; Kawakami K; Hattori H; Kobayashi K; Ogino Y; Fujikawa T; Satoh A; Kimura T; Noguchi K; Ohtake N; Tomimoto K
Bioorg Med Chem; 1999 Nov; 7(11):2555-67. PubMed ID: 10632066
[TBL] [Abstract][Full Text] [Related]
3. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
Mitsuya M; Kobayashi K; Kawakami K; Satoh A; Ogino Y; Kakikawa T; Ohtake N; Kimura T; Hirose H; Sato A; Numazawa T; Hasegawa T; Noguchi K; Mase T
J Med Chem; 2000 Dec; 43(26):5017-29. PubMed ID: 11150173
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonists.
Wang Y; Chackalamannil S; Chang W; Greenlee W; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
Bioorg Med Chem Lett; 2001 Apr; 11(7):891-4. PubMed ID: 11294385
[TBL] [Abstract][Full Text] [Related]
5. Novel imidazole derivatives with subtype-selective antimuscarinic activity (2).
Miyachi H; Kiyota H; Segawa M
Bioorg Med Chem Lett; 1998 Aug; 8(16):2163-8. PubMed ID: 9873506
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
Wang Y; Chackalamannil S; Hu Z; Clader JW; Greenlee W; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; McQuade R; Lachowicz JE
Bioorg Med Chem Lett; 2000 Oct; 10(20):2247-50. PubMed ID: 11055330
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.
Varoli L; Angeli P; Burnelli S; Marucci G; Recanatini M
Bioorg Med Chem; 1999 Sep; 7(9):1837-44. PubMed ID: 10530931
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
9. A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism.
Jooste E; Klafter F; Hirshman CA; Emala CW
Anesthesiology; 2003 Apr; 98(4):906-11. PubMed ID: 12657852
[TBL] [Abstract][Full Text] [Related]
10. A new series of M3 muscarinic antagonists based on the 4-amino-piperidine scaffold.
Diouf O; Gadeau S; Chellé F; Gelbcke M; Talaga P; Christophe B; Gillard M; Massingham R; Guyaux M
Bioorg Med Chem Lett; 2002 Sep; 12(18):2535-9. PubMed ID: 12182854
[TBL] [Abstract][Full Text] [Related]
11. Sulfide analogues as potent and selective M(2) muscarinic receptor antagonists.
Wang Y; Chackalamannil S; Hu Z; McKittrick BA; Greenlee W; Ruperto V; Duffy RA; Lachowicz JE
Bioorg Med Chem Lett; 2002 Apr; 12(7):1087-91. PubMed ID: 11909724
[TBL] [Abstract][Full Text] [Related]
12. Antagonists have a greater selectivity for muscarinic receptor subtypes in intact cerebellar granule cells than in membranes.
Saunders PA; Hough CJ; Chuang DM
Brain Res; 1996 Mar; 713(1-2):29-35. PubMed ID: 8724972
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
[TBL] [Abstract][Full Text] [Related]
14. The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists.
Wang ZP; Liu HZ; Zhu L; Hu YM; Cui YY; Niu YY; Lu Y; Chen HZ
Bioorg Med Chem; 2013 Mar; 21(5):1234-9. PubMed ID: 23375092
[TBL] [Abstract][Full Text] [Related]
15. Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists.
Wallis RM
Life Sci; 1995; 56(11-12):861-8. PubMed ID: 10188786
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic M3 receptor inactivation reveals a pertussis toxin-sensitive contractile response in the guinea pig colon: evidence for M2/M3 receptor interactions.
Sawyer GW; Ehlert FJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):464-76. PubMed ID: 10087039
[TBL] [Abstract][Full Text] [Related]
17. Discovery & development of selective M3 antagonists for clinical use.
Alabaster VA
Life Sci; 1997; 60(13-14):1053-60. PubMed ID: 9121347
[TBL] [Abstract][Full Text] [Related]
18. Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor.
Kozlowski JA; Lowe DB; Guzik HS; Zhou G; Ruperto VB; Duffy RA; McQuade R; Crosby G; Taylor LA; Billard W; Binch H; Lachowicz JE
Bioorg Med Chem Lett; 2000 Oct; 10(20):2255-7. PubMed ID: 11055332
[TBL] [Abstract][Full Text] [Related]
19. A role for M(2) and M(3) muscarinic receptors in the contraction of rat and human small airways.
Brown SM; Koarai A; Sturton RG; Nicholson AG; Barnes PJ; Donnelly LE
Eur J Pharmacol; 2013 Feb; 702(1-3):109-15. PubMed ID: 23396230
[TBL] [Abstract][Full Text] [Related]
20. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
Naito R; Takeuchi M; Morihira K; Hayakawa M; Ikeda K; Shibanuma T; Isomura Y
Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1286-94. PubMed ID: 9734316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
